Colorectal Cancer Clinical Trials in Maryland

Showing 221-240 of 319 trials

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

NCT03705013

The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.

Colorectal Cancer

Exact Sciences Corporation51 participantsStarted Oct 2018

Glendale, Arizona, United States • Mesa, Arizona, United States • Tempe, Arizona, United States +17 more locations

COMPLETEDPhase 312 miles

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

NCT00252564

The purpose of this study is to compare the rates of Progression-Free Survival (PFS) at 12 months for patients treated with Bev-FOLFOX versus patients treated with FOLF-CB for first line treatment of metastatic colorectal cancer.

Metastatic Colorectal Cancer

US Oncology Research247 participantsStarted Sep 2005

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sedona, Arizona, United States +79 more locations

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy

LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer

A Study in Second Line Metastatic Colorectal Cancer

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Using Patients' Social Contact to Improve Out-Patient Endoscopy Among Blacks

Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy

Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)

FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Interactive Cancer Communication System (ICCS) Directed Physical Activity Enhancement for Colon Cancer Survivors

A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer

A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

Sym004 in Patients With Advanced Solid Tumors

Other Conditions in Maryland